India's COVID-19 vaccine may come early? Emergency authorisation can be considered, says ICMR
India has two indigenous vaccine candidates Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila
The COVID-19 vaccine candidates coordinated by Bharat Biotech and Zydus Cadila are nearing completion of phase II trials
India is leaving no stone unturned in developing a vaccine against coronavirus infection. Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials. As the whole nation is eagerly waiting for a 'safe and effective' vaccine, there have been talks of 'emergency authorisation' of India's COVID-19 vaccine candidates.